In contrast to Pentraxin-3 and Galectin 3, Interleukin-1 Receptor-Like 1 levels did not show a significant differences across the groups, with levels of 28 ± 6 pg/mL in obese controls without CVD, 28 ± 8 pg/mL in T2DM patients, and 27 ± 10 pg/mL in HFpEF patients with T2DM (ANOVA, p = 0.928). The gene discussed is LGALS3; the disease is type 2 diabetes mellitus.